mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.005 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.006 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.006 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.008 |